At the Alliance Annual Conference in January 2025, Brian S. McGowan, PhD, FACEHP, led a session that introduced the critical need for a new perspective on assessment in continuing professional development (CPD) and continuing education (CE).

Although developments in cancer immunotherapy (immuno-oncology or I-O) continue to improve targeted treatments for patients with cancers such as melanoma and non-small cell lung cancer (NSCLC), there is an ongoing need for education that improves...

This article examines the outcomes of our experiment, offering valuable insights for both grant applicants and industry supporters. By sharing our successes, challenges and lessons learned, we hope to contribute to the ongoing improvement of...

Capturing great quotes from learners can be a challenge even for the most experienced CME/CE professional. If you find yourself struggling to ask good open-ended questions, you won’t want to miss “‘If You Build It, They Will...

Outcomes in CE have traditionally relied on pre- and post-education assessment of knowledge, competence and/or performance.

Over the past decade, our CE/CPD community has made significant progress in the science and delivery of outcomes. This work has contributed to the impact of various disease-state medical affairs goals across industry.

In part four of our ongoing series “Advancing Continuing Medical Education: Reflecting on the Past and Charting a Path Forward,” we shift focus to outcomes measurement as an integrated part of the educational design, identifying the...